FDA product code QXU: Esophageal Protection Device For Use In Percutaneous Cardiac Catheter Ablation Procedures, Mechanical Deviation

QXU is the FDA product code for esophageal protection device for use in percutaneous cardiac catheter ablation procedures, mechanical deviation. It is a Class II device, regulated under 21 CFR 870.5710 and reviewed by the Cardiovascular panel. FDA has cleared 1 510(k) submission under QXU, 1 in the last five years. The average 510(k) review took 31 days (median 31); 31 days on average over the last three years. 1 De Novo request was granted under it.

Definition

This device is placed in the lumen of the esophagus to reduce the likelihood of esophageal injury or a specific adverse event during cardiac ablation procedures. The device uses mechanical means to deviate the esophagus away from the source of ablation energy

Classification

FieldValue
Device nameEsophageal Protection Device For Use In Percutaneous Cardiac Catheter Ablation Procedures, Mechanical Deviation
Device classClass II
Regulation21 CFR 870.5710
Review panelCV — Cardiovascular
Medical specialtyCardiovascular
Premarket route510(k)

510(k) clearances per year for QXU

YearClearancesAvg. review days
2024131

Compare with all 510(k) review times · Search every QXU clearance

Top QXU applicants

ApplicantClearancesLatest
S4 Medical Corp.12024-11-09

Most recent QXU clearances

510(k)ApplicantDeviceDecision dateReview days
K243233S4 Medical Corp.esolution® Esophageal Retractor2024-11-0931

Recalls for QXU devices

openFDA lists no recalls for product code QXU.

Frequently asked questions

What is FDA product code QXU?

QXU is the FDA product code for esophageal protection device for use in percutaneous cardiac catheter ablation procedures, mechanical deviation. It is a Class II device, regulated under 21 CFR 870.5710 and reviewed by the Cardiovascular panel.

What device class is QXU?

Class II, regulation 21 CFR 870.5710. Typical premarket route: 510(k).

How long does a 510(k) take for product code QXU?

Across 1 cleared submissions the average was 31 days from receipt to decision (median 31).

Which companies have the most QXU clearances?

S4 Medical Corp. (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Cardiovascular product codes · FDA product code lookup · 510(k) database search · 510(k) review times